Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
Electra Therapeutics has raised $183.0M in total funding. The most recent round was Series C. The last funding was announced in October 2025.
Electra Therapeutics's investors include RA Capital Management, Cormorant Asset Management, Mubadala Capital, Sanofi, Blue Owl.
Electra Therapeutics is headquartered in San Francisco, United States.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
Electra Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Electra Therapeutics — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/electra-therapeutics. Accessed October 18, 2026.
VCBacked. (2025). Electra Therapeutics — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/electra-therapeutics
{{cite web |title=Electra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/electra-therapeutics |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated